Related Experiment Videos

[Type A adenocarcinoma grafted into C3H/he mice subjected to treatment with various antineoplastic agents. II.

Revista Espanola De Oncologia
|January 1, 1983
PubMed

Insights

Vincristine, prospidium chloride, and adriamycin treatments on adenocarcinoma in mice induced significant tumor necrosis and atypical cell structures. Viral particle counts decreased during treatment, suggesting drug efficacy.

Area of Science:

  • Oncology
  • Pharmacology
  • Pathology

Background:

  • Adenocarcinoma type A is a common cancer model in research.
  • Understanding drug effects on tumor microenvironment is crucial for treatment development.

Purpose of the Study:

  • To investigate the histopathological and ultrastructural effects of vincristine, prospidium chloride, and adriamycin on adenocarcinoma type A in C3 H/he-M mice.
  • To correlate observed cellular changes with the drugs' pharmacological mechanisms.

Main Methods:

  • Grafting adenocarcinoma type A to C3 H/he-M mice.
  • Treating tumor-bearing mice with vincristine, prospidium chloride, and adriamycin.
  • Histopathological and ultrastructural examination of tumor tissues using microscopy (M/O).

Main Results:

  • Prospidium chloride and adriamycin treatments led to increased connective stroma and extensive parenchymal necrosis.
  • Ultrastructural analysis revealed atypical mitoses with chromosomal fragmentations in treated tumors.
  • A reduction in viral particle numbers was observed across all treatment groups.

Conclusions:

  • Vincristine, prospidium chloride, and adriamycin exhibit cytotoxic effects on adenocarcinoma type A.
  • Observed ultrastructural changes, including chromosomal fragmentation, indicate the drugs' impact on cell division.
  • The decrease in viral particles suggests a potential oncolytic or antiviral effect of the chemotherapeutic agents.

Related Concept Videos